Cardiovascular Outcomes from the Latest COX-2 Randomized Trials
Results suggest that long-term use increases risk for cardiovascular thrombotic events in clinically stable patients and that short-term use increases risk in clinically unstable patients.
Continue to Cardiovascular Outcomes from the Latest COX-2 Randomized Trials on Medscape Headlines.
Medical Buzz delivers the most recent headlines from the medical world. Diseases, cures, accidents, medicin. Click below for more headlines ...
Medical buzz
